U.S. Drug Discovery Market to Hit USD 62.14 Billion by 2035 While Europe Advances Through Precision Medicine and Biologics Innovation. U.S. Drug Discovery Market to Hit USD 62.14 Billion by 2035 While Europe Advances Through Precision Medicine and Biologics I…
Key market opportunities in AI training datasets include the rising use of synthetic data to address data scarcity and privacy, increased demand for domain-specific datasets to enhance model accuracy, and automation in data labeling. Key sectors are healthcar…
The global colorectal cancer diagnostics and therapeutics market is witnessing steady growth due to the rising prevalence of colorectal cancer, increasing awareness about early screening, and advancements in precision medicine. Growing adoption of non-invasiv…
Asia-Pacific offers cost-effective growth. Precision medicine, chronic disease prevalence, and strategic partnerships further drive expansion in this evolving sector. Asia-Pacific offers cost-effective growth. Precision medicine, chronic disease prevalence, a…
The biosimulation market is witnessing robust expansion, fueled by the increasing adoption of model-informed drug development (MIDD), the growing complexity of modern drug development, and the rising emphasis on personalized and precision medicine. MIDD strat…